
Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
Keywords: عوارض جانبی; Pulmonary fibrosis; Serum amyloid P; PRM-151; First-in-human clinical trial; Pentraxin-2; Macrophage; Fibrocyte; AE; adverse events; ELISA; enzyme linked immunoassay; ERS/ATS; European Respiratory Society/American Thoracic Society; FACS; fluorescence acti